Biblio

Export 156 results:
[ Author(Desc)] Title Type Year
Filters: First Letter Of Last Name is G  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
G
A. Gerstenecker, Hoagey, D. A., Marson, D. C., and Kennedy, K. M., “White Matter Degradation is Associated with Reduced Financial Capacity in Mild Cognitive Impairment and Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 2, pp. 537-547, 2017.
E. Christiane Gertje, Pluta, J., Das, S., Mancuso, L., Kliot, D., Yushkevich, P., and Wolk, D., “Clinical Application of Automatic Segmentation of Medial Temporal Lobe Subregions in Prodromal and Dementia-Level Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1027-1037, 2016.
C. Gervaise-Henry, Watfa, G., Albuisson, E., Kolodziej, A., Dousset, B., Olivier, J. - L., Jonveaux, T. Rivasseau, and Malaplate-Armand, C., “Cerebrospinal Fluid Aβ42/Aβ40 as a Means to Limiting Tube- and Storage-Dependent Pre-Analytical Variability in Clinical Setting.”, J Alzheimers Dis, vol. 57, no. 2, pp. 437-445, 2017.
R. Ghidoni, Squitti, R., Siotto, M., and Benussi, L., “Innovative Biomarkers for Alzheimer's Disease: Focus on the Hidden Disease Biomarkers.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1507-1518, 2018.
G. Giaccone, “The Existence of Primary Age-Related Tauopathy Suggests that not all the Cases with Early Braak Stages of Neurofibrillary Pathology are Alzheimer's Disease.”, J Alzheimers Dis, 2015.
M. Pia Giannoccaro, Bartoletti-Stella, A., Piras, S., Casalena, A., Oppi, F., Ambrosetto, G., Montagna, P., Liguori, R., Parchi, P., and Capellari, S., “The First Historically Reported Italian Family with FTD/ALS Teaches a Lesson on C9orf72 RE: Clinical Heterogeneity and Oligogenic Inheritance.”, J Alzheimers Dis, vol. 62, no. 2, pp. 687-697, 2018.
V. Giannouli, Stamovlasis, D., and Tsolaki, M., “Exploring the Role of Cognitive Factors in a New Instrument for Elders' Financial Capacity Assessment.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1579-1594, 2018.
L. M. Giil, Vedeler, C. A., Kristoffersen, E. K., Nordrehaug, J. Erik, Heidecke, H., Dechend, R., Schulze-Forster, K., Muller, D. N., von Goetze, V. S., Cabral-Marques, O., Riemekasten, G., Vogelsang, P., Nygaard, S., Lund, A., and Aarsland, D., “Antibodies to Signaling Molecules and Receptors in Alzheimer's Disease are Associated with Psychomotor Slowing, Depression, and Poor Visuospatial Function.”, J Alzheimers Dis, vol. 59, no. 3, pp. 929-939, 2017.
L. Melvaer Giil, Midttun, Ø., Refsum, H., Ulvik, A., Advani, iv, R., A Smith, D., and Ueland, P. Magne, “Kynurenine Pathway Metabolites in Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 2, pp. 495-504, 2017.
L. M. Giil, Aarsland, D., Hellton, K., Lund, A., Heidecke, H., Schulze-Forster, K., Riemekasten, G., Vik-Mo, A. Osland, Kristoffersen, E. K., Vedeler, C. A., and Nordrehaug, J. Erik, “Antibodies to Multiple Receptors are Associated with Neuropsychiatric Symptoms and Mortality in Alzheimer's Disease: A Longitudinal Study.”, J Alzheimers Dis, vol. 64, no. 3, pp. 761-774, 2018.
M. José Gil, Manzano, M. Sagrario, Cuadrado, M. Luz, Fernández, C., Góméz, E., Matesanz, C., Calero, M., and Rábano, A., “Argyrophilic Grain Pathology in Frontotemporal Lobar Degeneration: Demographic, Clinical, Neuropathological, and Genetic Features.”, J Alzheimers Dis, vol. 63, no. 3, pp. 1109-1117, 2018.
R. Gil and Arroyo-Anlló, E. M., “Alzheimer's Disease and Face Masks in Times of COVID-19.”, J Alzheimers Dis, vol. 79, no. 1, pp. 9-14, 2021.
T. Gilbert, Roche, S., Blond, E., Bar, J. - Y., Drai, J., Cuerq, C., Haution-Bitker, M., Ecochard, R., and Bonnefoy, M., “Association between Peripheral Leptin and Adiponectin Levels and Cognitive Decline in Patients with Neurocognitive Disorders ≥65 Years.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1255-1264, 2018.
S. Gill, Mouches, P., Hu, S., Rajashekar, D., MacMaster, F. P., Smith, E. E., Forkert, N. D., and Ismail, Z., “Using Machine Learning to Predict Dementia from Neuropsychiatric Symptom and Neuroimaging Data.”, J Alzheimers Dis, vol. 75, no. 1, pp. 277-288, 2020.
J. F. - M. Gilmartin-Thomas, McNeil, J., Powell, A., Malone, D. T., Wolfe, R., Larson, I. C., O'Reilly, C. L., Kirkpatrick, C. M., Kipen, E., Petrovich, T., and J Bell, S., “Impact of a Virtual Dementia Experience on Medical and Pharmacy Students' Knowledge and Attitudes Toward People with Dementia: A Controlled Study.”, J Alzheimers Dis, vol. 62, no. 2, pp. 867-876, 2018.
D. A. Gimbel, Nygaard, H. B., Coffey, E. E., Gunther, E. C., Laurén, J., Gimbel, Z. A., and Strittmatter, S. M., “Memory impairment in transgenic Alzheimer mice requires cellular prion protein.”, J Neurosci, vol. 30, no. 18, pp. 6367-74, 2010.
L. GjØra, Strand, B. Heine, Bergh, S., Borza, T., Brækhus, A., Engedal, K., Johannessen, A., Kvello-Alme, M., Krokstad, S., Livingston, G., Matthews, F. E., Myrstad, C., Skjellegrind, H., Thingstad, P., Aakhus, E., Aam, S., and Selbæk, G., “Current and Future Prevalence Estimates of Mild Cognitive Impairment, Dementia, and Its Subtypes in a Population-Based Sample of People 70 Years and Older in Norway: The HUNT Study.”, J Alzheimers Dis, vol. 79, no. 3, pp. 1213-1226, 2021.
C. E. Gleason, Fischer, B. L., N Dowling, M., Setchell, K. D. R., Atwood, C. S., Carlsson, C. M., and Asthana, S., “Cognitive Effects of Soy Isoflavones in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 47, no. 4, pp. 1009-19, 2015.
C. E. Gleason, Norton, D., Anderson, E. D., Wahoske, M., Washington, D. T., Umucu, E., Koscik, R. L., N Dowling, M., Johnson, S. C., Carlsson, C. M., and Asthana, S., “Cognitive Variability Predicts Incident Alzheimer's Disease and Mild Cognitive Impairment Comparable to a Cerebrospinal Fluid Biomarker.”, J Alzheimers Dis, vol. 61, no. 1, pp. 79-89, 2018.
H. Glonnegger, Beyle, A., Cerff, B., Gräber, S., Csoti, I., Berg, D., and Liepelt-Scarfone, I., “The Multiple Object Test as a Performance Based Tool to Assess Cognitive Driven Activity of Daily Living Function in Parkinson's Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1475-84, 2016.
T. Glozman, Solomon, J., Pestilli, F., and Guibas, L., “Shape-Attributes of Brain Structures as Biomarkers for Alzheimer's Disease.”, J Alzheimers Dis, vol. 56, no. 1, pp. 287-295, 2017.
O. Godefroy, Bakchine, S., Verny, M., Delabrousse-Mayoux, J. - P., Roussel, M., and Pere, J. - J., “Characteristics of Alzheimer's Disease Patients with Severe Executive Disorders.”, J Alzheimers Dis, vol. 51, no. 3, pp. 815-25, 2016.
J. Godin, Armstrong, J. J., Rockwood, K., and Andrew, M. K., “Dynamics of Frailty and Cognition After Age 50: Why It Matters that Cognitive Decline is Mostly Seen in Old Age.”, J Alzheimers Dis, vol. 58, no. 1, pp. 231-242, 2017.
T. E. Golde, Schneider, L. S., and Koo, E. H., “Anti-aβ therapeutics in Alzheimer's disease: the need for a paradigm shift.”, Neuron, vol. 69, no. 2, pp. 203-13, 2011.
H. L. Golden, Clark, C. N., Nicholas, J. M., Cohen, M. H., Slattery, C. F., Paterson, R. W., Foulkes, A. J. M., Schott, J. M., Mummery, C. J., Crutch, S. J., and Warren, J. D., “Music Perception in Dementia.”, J Alzheimers Dis, vol. 55, no. 3, pp. 933-949, 2017.

Pages